Kazam Joshua A
SEC CIK 1221355 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ALLO | Allogene Therapeutics, Inc. | Dir | 398.5K | $189.0K | — | 6 | 2022-01-12 | 2026-06-18 |
Most active insiders at ALLO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Chang David D | Pres, CEO, Dir | — | $289.5K |
| 2 | Roberts Zachary | EVP of R, D | — | $104.2K |
| 3 | Douglas Earl Martin | SVP, GC | — | $103.3K |
| 4 | Parker Geoffrey M. | CFO | — | $88.5K |
| 5 | Beneski Benjamin Machinas | SVP, Chief Technical Off | — | $51.7K |
| 6 | Yoshiyama Annie | SVP, Fin | — | $29.3K |
| 7 | Kazam Joshua A | Dir | — | — |
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-23 16:35 | 2026-06-18 | ALLO | Allogene Therapeutics, Inc. | Kazam Joshua A | Dir | M - OptEx | $0.00 | +47.7K | 398.5K | +14% | $0 |
| D | 2025-12-22 | 2025-12-18 | ALLO | Allogene Therapeutics, Inc. | Kazam Joshua A | Dir | M - OptEx | $0.00 | +47.7K | 350.8K | +16% | $0 |
| 2022-06-17 | 2022-06-15 | ALLO | Allogene Therapeutics, Inc. | Kazam Joshua A | Dir | A - Grant | $0.00 | +44.2K | 303.1K | +17% | $0 | |
| 2022-03-09 | 2022-03-07 | ALLO | Allogene Therapeutics, Inc. | Kazam Joshua A | Dir | J - Other | $0.00 | +412.6K | 671.5K | +159% | $0 | |
| 2022-03-09 | 2022-03-07 | ALLO | Allogene Therapeutics, Inc. | Kazam Joshua A | Dir | G - Gift | $0.00 | -412.6K | 258.9K | -61% | $0 | |
| 2022-01-14 | 2022-01-12 | ALLO | Allogene Therapeutics, Inc. | Kazam Joshua A | Dir | P - Purchase | $12.60 | +15.0K | 258.9K | +6% | +$189.0K |
Purchase Sale Sale after option exercise All abbreviations